Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy reported $180.1 million in revenue and $53.8 million in expenses for calendar year 2025. Of every $100 it spent, $86.95 went to program services, $12.18 to management and general costs and $0.87 to fundraising. Its largest source of revenue was contributions and grants: 97.2% of the total. The highest compensation it reported for one person was $886,463 (CHIEF BUSINESS OFF. THRU 8/25). 27 people received more than $100,000 in reportable compensation. Revenue rose 11% between 2019 and 2025. Source: Form 990, 2025.
Where $100 of spending went
Calendar year 2025 · Form 990, Part IX, line 25 · total expenses $54MFor context, the median across 5,634 covered health care charities: $86.19 programs, $13.81 management, $0.00 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2025 · Form 990, Part VIII · total revenue $180MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 87.0% | 85.6% |
| Management & general Part IX 25(C) ÷ 25(A) | 12.2% | 13.7% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.9% | 0.0% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.00 | $0.00 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 97.2% | 1.3% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.1% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.7% | 93.7% |
| Highest reported compensation Part VII-A, columns D–F | $886,463 | $975,831 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 1.65% | 1.34% |
| People paid over $100,000 Part VII, line 2 | 27 | 27 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 61.7 | 6.6 |
| Independent voting board members Part VI 1a–1b | 14 of 15 | 88.9% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2025 · Form 990, Part III · the three largest programs by expenseParker Institute for Cancer Immunotherapy (pici) encourages advances in Cancer Immunotherapy research, collaboration, and discovery, and the translation of these advances into cures and treatments for the benefit of patients. To do this, pici partners with its consortium of preeminent hospitals and academic research centers to conduct its discovery and clinical research and provides its partners with shared research resources, such as scientific equipment, consumables, bioinformatics analysis, and a specimen biobank. Pici also funds and otherwise supports Cancer Immunotherapy research within…
Highest reported compensation
2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| CHIEF BUSINESS OFF. THRU 8/25 Highest compensated employee, 40.0 hrs/week | $791,771 | $0 | $94,692 | $886,463 |
| CHIEF SCIENTIFIC OFFICER Key employee, 40.0 hrs/week | $703,149 | $0 | $75,026 | $778,175 |
| CEO AS OF 03/2025 Director/trustee, officer, 40.0 hrs/week | $655,478 | $0 | $58,978 | $714,456 |
| CHIEF LEGAL OFFICER Key employee, 40.0 hrs/week | $623,269 | $0 | $75,194 | $698,463 |
| SR DIR, NETWORK CLIN. RESEARCH Highest compensated employee, 40.0 hrs/week | $314,624 | $0 | $200,315 | $514,939 |
| SR VP FINANCE & ADMIN. Key employee, 40.0 hrs/week | $444,632 | $0 | $51,918 | $496,550 |
| SENIOR VP, STRAT. OPS. & COMMS Highest compensated employee, 40.0 hrs/week | $441,686 | $0 | $32,245 | $473,931 |
| SR MEDICAL DIR, HEAD OF MED Highest compensated employee, 40.0 hrs/week | $398,778 | $0 | $21,808 | $420,586 |
27 people received more than $100,000 in reportable compensation from Parker Institute for Cancer Immunotherapy (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.7M (Part IX, line 5).
7 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b15 · 14 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2Yes
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26Yes
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 531
- Volunteers Part I, line 620
Private foundation grants it received
4 private foundations reported grants to Parker Institute for Cancer Immunotherapy totaling $2,183 on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from Parker Institute for Cancer Immunotherapy's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Parker Institute for Cancer Immunotherapy, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Parker Institute for Cancer Immunotherapy spent in 2025, $86.95 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- AllosourceCentennial, CO · revenue $180M · programs 93.2% · 2024
- United Memorial Medical CenterBatavia, NY · revenue $180M · programs 86.3% · 2024
- Nazareth HospitalNewtown Square, PA · revenue $180M · programs 82.7% · FY2025
- Children's NationalWashington, DC · revenue $180M · FY2025
- Upper Valley Medical CenterDayton, OH · revenue $180M · programs 96.2% · 2024
Questions people ask
How much of Parker Institute for Cancer Immunotherapy's spending goes to programs?
In calendar year 2025, Parker Institute for Cancer Immunotherapy reported that 87.0% of its $53.8 million in expenses went to program services, 12.2% to management and general and 0.9% to fundraising (Form 990, Part IX).
How much does Parker Institute for Cancer Immunotherapy pay its top executive?
The largest total compensation Parker Institute for Cancer Immunotherapy reported for one person in calendar year 2025 was $886,463, for the role of CHIEF BUSINESS OFF. THRU 8/25 (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Parker Institute for Cancer Immunotherapy get its money?
Of $180.1 million in revenue in calendar year 2025, 97.2% came from contributions and grants and 0.7% from program service revenue (Form 990, Part VIII).
Is Parker Institute for Cancer Immunotherapy a registered charity?
The IRS lists EIN 47-3355381 as a 501(c)(3) organization (hospital or medical research organization), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024, 2025. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2025: Form 990 for calendar year 2025, object 202632189349300148 · read the filing
- 2024: Form 990 for calendar year 2024, object 202502129349301525 · read the filing
- 2023: Form 990 for calendar year 2023, object 202442149349301434 · read the filing
- 2022: Form 990 for calendar year 2022, object 202303189349306385 · read the filing
- 2021: Form 990 for calendar year 2021, object 202213149349305531 · read the filing
- 2020: Form 990 for calendar year 2020, object 202103169349307275 · read the filing
- 2019: Form 990 for calendar year 2019, object 202043219349313849 · read the filing
All filings for EIN 47-3355381: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.